Alkermes (ALKS) Treasury Shares (2011 - 2026)
Alkermes (ALKS) posted quarterly Treasury Shares of $502.5 million for Q2 2026, up 11.74% year-over-year from $449.7 million in Q2 2025, and little changed quarter-over-quarter from $501.4 million in Q1 2026.
Alkermes (ALKS) Treasury Shares (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Treasury Shares for 16 consecutive years, with $502.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Treasury Shares rose 11.74% year-over-year to $502.5 million; the TTM figure through Jun 2026 stood at $502.5 million (up 11.74% YoY), while the FY2025 annual figure was $450.3 million, up 7.4% from the prior year.
- Treasury Shares held at $502.5 million in Q2 2026 per ALKS's latest filing, from $501.4 million in the prior quarter.
- Across five years, Treasury Shares topped out at $17.2 million in Q2 2026 and bottomed at -$17.1 million in Q1 2026.
- Historically, Treasury Shares has averaged -$1.4 million across 5 years, with a median of -$21376.5 in 2022.
- Annual changes were most pronounced in 2024 — Treasury Shares surged 124.09% — and 2025, when it increased 7.4%.
- Alkermes' Treasury Shares stood at $160.9 million in 2022, then climbed by 17.7% to $189.3 million in 2023, then jumped by 121.43% to $419.3 million in 2024, then gained by 7.4% to $450.3 million in 2025, then gained by 11.6% to $502.5 million in 2026.
- Business Quant data shows ALKS's Treasury Shares at $502.5 million in Q2 2026, $501.4 million in Q1 2026, and $450.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 19.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 502.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 502.52 Mn |
| Jun 30, 2026 | 17.16 Mn |
| Jun 30, 2026 | 502.52 Mn |
| Jun 30, 2026 | 17.16 Mn |
| Mar 31, 2026 | 501.43 Mn |
| Mar 31, 2026 | -17.13 Mn |
| Mar 31, 2026 | 501.43 Mn |
| Mar 31, 2026 | -17.13 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Dec 31, 2025 | 450.29 Mn |
| Dec 31, 2025 | 450.29 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Sep 30, 2025 | 450.02 Mn |
| Sep 30, 2025 | 15.40 Mn |
| Sep 30, 2025 | 15.40 Mn |
| Sep 30, 2025 | 450.02 Mn |
| Jun 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | 449.71 Mn |
| Jun 30, 2025 | 449.71 Mn |
| Jun 30, 2025 | -15.38 Mn |